A detailed history of Simplex Trading, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 64,183 shares of ABCL stock, worth $187,414. This represents 0.01% of its overall portfolio holdings.

Number of Shares
64,183
Previous 37,185 72.6%
Holding current value
$187,414
Previous $110,000 50.91%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$2.39 - $3.49 $64,525 - $94,223
26,998 Added 72.6%
64,183 $166,000
Q2 2024

Jul 25, 2024

SELL
$2.73 - $4.73 $44,468 - $77,046
-16,289 Reduced 30.46%
37,185 $110,000
Q1 2024

Apr 25, 2024

SELL
$4.29 - $5.97 $14,525 - $20,214
-3,386 Reduced 5.95%
53,474 $242,000
Q4 2023

Feb 02, 2024

BUY
$3.91 - $5.93 $206,647 - $313,406
52,851 Added 1318.31%
56,860 $324,000
Q3 2023

Nov 01, 2023

SELL
$4.6 - $7.95 $6,683 - $11,551
-1,453 Reduced 26.6%
4,009 $18,000
Q2 2023

Aug 04, 2023

SELL
$5.66 - $7.59 $33,309 - $44,667
-5,885 Reduced 51.86%
5,462 $35,000
Q1 2023

Apr 27, 2023

SELL
$7.31 - $11.18 $651,642 - $996,629
-89,144 Reduced 88.71%
11,347 $85,000
Q4 2022

Feb 02, 2023

BUY
$9.48 - $14.52 $376,403 - $576,516
39,705 Added 65.32%
100,491 $1.02 Million
Q3 2022

Nov 04, 2022

BUY
$9.2 - $13.68 $331,236 - $492,534
36,004 Added 145.28%
60,786 $601,000
Q2 2022

Aug 03, 2022

SELL
$5.72 - $10.65 $149,715 - $278,753
-26,174 Reduced 51.37%
24,782 $263,000
Q1 2022

May 02, 2022

SELL
$7.46 - $14.14 $257,131 - $487,377
-34,468 Reduced 40.35%
50,956 $496,000
Q4 2021

Feb 23, 2022

BUY
$12.99 - $17.73 $742,274 - $1.01 Million
57,142 Added 202.04%
85,424 $1.22 Million
Q3 2021

Oct 28, 2021

BUY
$14.85 - $21.34 $14,256 - $20,486
960 Added 3.51%
28,282 $581,000
Q2 2021

Aug 12, 2021

BUY
$20.19 - $34.17 $487,628 - $825,273
24,152 Added 761.89%
27,322 $601,000
Q1 2021

Apr 26, 2021

BUY
$23.29 - $53.2 $73,829 - $168,644
3,170 New
3,170 $107,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.